
A new ophthalmic formulation of bimatoprost was found to improve adherence and persistence compared with the original formulation of bimatoprost.

A new ophthalmic formulation of bimatoprost was found to improve adherence and persistence compared with the original formulation of bimatoprost.

A small proportion of patients with chronic conditions have very high healthcare expenditures, and a trend was observed toward increasing coinsurance requirements.

Published: April 7th 2011 | Updated:

Published: December 14th 2016 | Updated: